Alloy Therapeutics

Series-B
82vs.com Biotech & Healthcare
Total Funding $40M
Latest Round $40M Series-B
Last Announced Apr 15, 2026
Investors Undisclosed
Decision Makers Profile Active

About Alloy Therapeutics

Offers drug discovery platforms and services for antibodies, bispecifics, TCR mimics, and genetic medicines.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website 82vs.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $40,000,000 · Series-B

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Alloy Therapeutics.

Funding History

1 Round
Series-B equity · Apr 15, 2026

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts